Literature DB >> 17185902

Heterophilic antibodies causing falsely high serum calcitonin values.

P D Papapetrou1, A Polymeris, H Karga, G Vaiopoulos.   

Abstract

Heterophilic antibodies (HA) may interfere in some immunoassays, causing falsely high hormone values, of which practitioners should be aware when measuring calcitonin (CT) used as tumor marker for medullary thyroid carcinoma (MTC). We studied four patients with thyroid nodules, three of whom underwent surgical neck exploration, after an erroneous diagnosis of MTC because of falsely high serum CT eventually proved to be due to HA. One patient had a lingual thyroid, two autoimmune thyroiditis and the fourth a colloid goiter. The minimal incremental CT response to calcium infusion raised our suspicion of possible false high CT values due to HA. There was no linearity of the CT values obtained by testing serial dilutions of the sera in the CT assay, which employs two monoclonal mouse anti-CT antibodies. Addition of normal mouse gamma globulin eliminated the interference by HA in the sera of two patients. Serum assayed in a polyclonal radioimmunoassay using goat anti-CT antibodies gave normal CT values. Finally, incubation of the sera in Heterophilic Blocking Tubes (HBT) eliminated the false CT immunoreactivity. A spontaneous change of the CT serum concentrations was noticed in three patients over several months, apparently due to changing titles of HA. We suggest that, in patients a) whose CT response to calcium or pentagastrin infusion is minimal despite high basal CT values, b) with autoimmune thyroiditis and c) in whom an unexpected change in serum CT concentrations occurs, the possibility of spuriously high CT values because of circulating HA should be considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17185902     DOI: 10.1007/BF03349197

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  14 in total

Review 1.  The calcitonin conundrum--is it time for routine measurement of serum calcitonin in patients with thyroid nodules?

Authors:  Steven P Hodak; Kenneth D Burman
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

2.  Heterophilic antibodies remain a problem for the immunoassay laboratory.

Authors:  G Ward; L McKinnon; T Badrick; P E Hickman
Journal:  Am J Clin Pathol       Date:  1997-10       Impact factor: 2.493

3.  Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group.

Authors:  P Niccoli; N Wion-Barbot; P Caron; J F Henry; C de Micco; J P Saint Andre; J C Bigorgne; E Modigliani; B Conte-Devolx
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

4.  False serum calcitonin high levels using a non-competitive two-site IRMA.

Authors:  M Tommasi; A Brocchi; A Cappellini; S Raspanti; M Mannelli
Journal:  J Endocrinol Invest       Date:  2001-05       Impact factor: 4.256

Review 5.  Human anti-animal antibody interferences in immunological assays.

Authors:  L J Kricka
Journal:  Clin Chem       Date:  1999-07       Impact factor: 8.327

6.  Clinical evaluation of a new sensitive calcitonin assay: study of specificity.

Authors:  M d'Herbomez; L Leclerc; M C Vantyghem; F Fourrier; C Proye; J L Wemeau
Journal:  Clin Chim Acta       Date:  2001-09-25       Impact factor: 3.786

7.  Mild persistent hypercalcitoninemia after total thyroidectomy in patients with papillary thyroid carcinoma.

Authors:  Kazuki Yokoi; Tsuneo Imai; Arihiro Shibata; Yatsuka Hibi; Toyone Kikumori; Hiroomi Funahashi; Akimasa Nakao
Journal:  Endocr J       Date:  2003-08       Impact factor: 2.349

8.  Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays.

Authors:  Carol M Preissner; Dennis J O'Kane; Ravinder J Singh; John C Morris; Stefan K G Grebe
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

9.  Calcitonin levels are similar in goitrous euthyroid patients with or without thyroid antibodies, as well as in hypothyroid patients.

Authors:  H Pantazi; P D Papapetrou
Journal:  Eur J Endocrinol       Date:  1998-05       Impact factor: 6.664

10.  Calcitonin secretion in congenital nongoitrous cretinism.

Authors:  D E Carey; K L Jones; J G Parthemore; L J Deftos
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

View more
  3 in total

1.  Rheumatoid factor and its interference with cytokine measurements: problems and solutions.

Authors:  Else Marie Bartels; Inger Falbe Wätjen; Eva Littrup Andersen; Bente Danneskiold-Samsøe; Henning Bliddal; Søren Ribel-Madsen
Journal:  Arthritis       Date:  2011-06-22

Review 2.  Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma.

Authors:  Sergio P A Toledo; Delmar M Lourenço; Marcelo Augusto Santos; Marcos R Tavares; Rodrigo A Toledo; Joya Emilie de Menezes Correia-Deur
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

3.  Serum sample containing endogenous antibodies interfering with multiple hormone immunoassays. Laboratory strategies to detect interference.

Authors:  Elena García-González; Maite Aramendía; Diego Álvarez-Ballano; Pablo Trincado; Luis Rello
Journal:  Pract Lab Med       Date:  2015-11-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.